Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409796 · ClinicalTrials.gov registry record · NA
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
A NA study, sponsored by Takeda.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03409796 is a NA study that has completed, run by Takeda. The registered enrollment target is 16 participants.
The verdict
NCT03409796, a NA study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The primary purpose of this study is to characterize changes in gluten-specific T cells and pathology in the small intestine with specific focus on biomarkers likely to change with therapeutic celiac disease (CeD) treatment.
Interventions
- DIETARY_SUPPLEMENT Gluten
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-04-24 |
| Est. Completion | 2019-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03409796
The ClinicalTrials.gov registry entry for NCT03409796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gluten is the first listed.
NCT03409796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03409796 about?
NCT03409796 is a clinical study titled "Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge". The primary purpose of this study is to characterize changes in gluten-specific T cells and pathology in the small intestine with specific focus on biomarkers likely to change with therapeutic celiac disease (CeD) treatment.
What is the current status of trial NCT03409796?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-04-24. Estimated completion is 2019-05-02.
What interventions are being tested in trial NCT03409796?
The interventions under investigation include: Gluten (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03409796?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.